bluebird bio, Inc. Quarterly Cost of Revenue in USD from Q1 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
bluebird bio, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2022 to Q2 2024.
  • bluebird bio, Inc. Cost of Revenue for the quarter ending June 30, 2024 was $28.9M, a 332% increase year-over-year.
  • bluebird bio, Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $76.1M, a 522% increase year-over-year.
  • bluebird bio, Inc. annual Cost of Revenue for 2023 was $33.5M, a 233% increase from 2022.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $76.1M $28.9M +$22.2M +332% Apr 1, 2024 Jun 30, 2024 10-Q 2024-09-27
Q1 2024 $53.9M $25.9M +$20.4M +369% Jan 1, 2024 Mar 31, 2024 10-Q 2024-09-13
Q4 2023 $33.5M $10.4M +$10.3M +47005% Oct 1, 2023 Dec 31, 2023 10-K 2024-09-13
Q3 2023 $23.2M $11M +$11M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $12.2M $6.7M +$4.95M +284% Apr 1, 2023 Jun 30, 2023 10-Q 2024-09-27
Q1 2023 $7.28M $5.51M -$2.8M -33.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-09-13
Q4 2022 $10.1M $22K Oct 1, 2022 Dec 31, 2022 10-K 2024-09-13
Q3 2022 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $1.75M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $8.31M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.